A toxicology study to evaluate the embryotoxicity of metformin compared with the hypoglycemic drugs, the anticancer drug, the anti‐epileptic drug, the antibiotic, and the cyclo‐oxygenase (COX)‐2 inhibitor

Li Li,Xing Zhang,Lei Wang,Zhenhai Chai,Xiuping Shen,Zong-peng Zhang,Changxiao Liu
DOI: https://doi.org/10.1111/1753-0407.12251
IF: 4.53
2015-11-01
Journal of Diabetes
Abstract:The safe use of medications in pregnant females, their embryos and in offspring is important. The aim of the present study was to evaluate embryotoxicity of metformin (MET) compared with other hypoglycemic drugs (rosiglitazone [RSG] and glimepiride [GLIM]), the anticancer drug 5‐fluorouracil (5‐FU), the anti‐epileptic drug diphenylhydantoin (DPH), the antibiotic penicillin G (PenG), and the cyclo‐oxygenase (COX)‐2 inhibitor nimesulide (NIM) in an embryonic stem cell test (EST).
Medicine
What problem does this paper attempt to address?